- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4188 - 1,3-Diazoles condensed with heterocyclic ring systems, e.g. biotin, sorbinil
Patent holdings for IPC class A61K 31/4188
Total number of patents in this class: 1778
10-year publication summary
|
153
|
155
|
154
|
177
|
137
|
152
|
131
|
133
|
116
|
59
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2031 |
37 |
| University of Southern California | 2114 |
28 |
| Novartis AG | 10886 |
23 |
| Achillion Pharmaceuticals, Inc. | 165 |
23 |
| Boehringer Ingelheim International GmbH | 4697 |
22 |
| Genentech, Inc. | 3979 |
18 |
| The Johns Hopkins University | 5652 |
18 |
| DSM IP Assets B.V. | 5603 |
17 |
| Merck Sharp & Dohme LLC | 3751 |
17 |
| F. Hoffmann-La Roche AG | 7934 |
15 |
| Janssen Pharmaceutica N.V. | 3396 |
15 |
| Bristol-myers Squibb Company | 4879 |
14 |
| Société des Produits Nestlé S.A. | 9252 |
12 |
| AstraZeneca AB | 2928 |
11 |
| Merck Patent GmbH | 5873 |
11 |
| Takeda Pharmaceutical Company Limited | 2712 |
11 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 300 |
11 |
| Shanghai Hansoh Biomedical Co., Ltd. | 259 |
11 |
| Gilead Pharmasset LLC | 40 |
10 |
| Neurophyxia B.V. | 12 |
10 |
| Other owners | 1444 |